MUNCY COLUMBIA FINANCIAL Corp CCFN Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0001999371-25-005747
cik 731122
name MUNCY COLUMBIA FINANCIAL CORP
sic 6022
countryba US
stprba PA
cityba BLOOMSBURG
zipba 17815
bas1 232 EAST ST
bas2
baph 5707844400
countryma US
stprma PA
cityma BLOOMSBURG
zipma 17815
mas1 232 EAST STREET
mas2
countryinc US
stprinc PA
ein 232254643
former CCFNB BANCORP INC
changed 19920703
afs 4-NON
wksi 0
fye 1231
form 10-Q
period 20250331
fy 2025
fp Q1
filed 20250509
accepted 2025-05-09 11:21:00.0
prevrpt 0
detail 1
instance ccfn-10q_033125_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001999371-25-005747 20250331 Debt Securities Available For Sale Realized Gain Loss USD 1 us-gaap/2025
0001999371-25-005747 20240331 Common Stock Dividends Per Share Cash Paid 0.4400 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Common Stock Shares Authorized 15000000.0000 shares 0 us-gaap/2025
0001999371-25-005747 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2025 Equity Components= Common Stock;
0001999371-25-005747 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 5000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 5000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001999371-25-005747 20250331 Amortization Of Investment In Limited Partnerships 187000.0000 USD 1 0001999371-25-005747
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Debt Obligations;
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Debt Securities;
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Collateralized Debt Obligations;
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Debt Obligations;
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities 323248000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities 279000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Debt Securities;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mortgage Backed Securities;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities 106619000.0000 USD 0 us-gaap/2025 Financial Instrument= Other Debt Securities;
0001999371-25-005747 20250331 Cash And Due From Banks 13781000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 16231000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20241231 Common Stock Value 4802000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Communication 839000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Depreciation Nonproduction 370000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Dividends Common Stock Cash 1590000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Dividends Common Stock Cash USD 1 us-gaap/2025 Equity Components= Treasury Stock Common;
0001999371-25-005747 20250331 Earnings Per Share Basic 1.2300 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Equipment Expense 406000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Equity Securities Fv Ni Current And Noncurrent 1355000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20241231 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 931000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Portfolio Segment;
0001999371-25-005747 20241231 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 1850000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Residential Portfolio Segment;
0001999371-25-005747 20250331 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 6409000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 169000.0000 USD 0 us-gaap/2025 Financial Instrument Performance Status= Nonperforming Financing Receivable; Financing Receivable Portfolio Segment= Consumer And Other;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 21681000.0000 USD 0 us-gaap/2025 Financial Instrument Performance Status= Performing Financing Receivable; Financing Receivable Portfolio Segment= Consumer And Other;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 9316000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Portfolio Segment; Internal Credit Assessment= Substandard;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 660802000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Residential Consumer And Other;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 2326000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Residential Real Estate; Financing Receivables Period Past Due= Financing Receivables60 To89 Days Past Due;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 6195000.0000 USD 0 us-gaap/2025 Financing Receivables Period Past Due= Financing Receivables Equal To Greater Than90 Days Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 6950000.0000 USD 0 us-gaap/2025 Financial Instrument Performance Status= Nonperforming Financing Receivable; Financing Receivable Portfolio Segment= Residential Portfolio Segment;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 93070000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial; Financing Receivables Period Past Due= Financial Asset Not Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 836000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial; Financing Receivables Period Past Due= Financing Receivables Equal To Greater Than90 Days Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 93932000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial Portfolio Segment;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 25000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial Portfolio Segment; Internal Credit Assessment= Special Mention;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 373177000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate; Financing Receivables Period Past Due= Financial Asset Not Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 5878000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Commercial And Industrial Portfolio Segment; Internal Credit Assessment= Special Mention;
0001999371-25-005747 20250331 Gains Losses On Sales Of Other Real Estate -51000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Interest Bearing Deposit Liabilities 1064852000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Interest Bearing Deposit Liabilities 357211000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3;
0001999371-25-005747 20250331 Interest Bearing Deposits In Banks 9978000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Interest Income Expense After Provision For Loan Loss 13758000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Interest Payable Current And Noncurrent USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1;
0001999371-25-005747 20241231 Interest Payable Current And Noncurrent 1857000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2;
0001999371-25-005747 20250331 Interest Payable Current And Noncurrent 1864000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2;
0001999371-25-005747 20241231 Interest Receivable USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1;
0001999371-25-005747 20250331 Loans Receivable Held For Sale Amount 1782000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Net Cash Provided By Used In Investing Activities 64760000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Net Cash Provided By Used In Operating Activities 3878000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Net Income Loss USD 1 us-gaap/2025 Equity Components= Common Stock;
0001999371-25-005747 20250331 Net Income Loss 4345000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001999371-25-005747 20250331 Noncash Merger Related Costs USD 1 us-gaap/2025
0001999371-25-005747 20241231 Noninterest Bearing Deposit Liabilities 259700000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2;
0001999371-25-005747 20250331 Noninterest Bearing Deposit Liabilities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1;
0001999371-25-005747 20250331 Noninterest Bearing Deposit Liabilities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3;
0001999371-25-005747 20240331 Noninterest Income Other Operating Income 690000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Other Comprehensive Income Loss Net Of Tax -1490000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Other Comprehensive Income Loss Net Of Tax USD 1 us-gaap/2025 Equity Components= Treasury Stock Common;
0001999371-25-005747 20240331 Proceeds From Other Deposits 248000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Proceeds From Repayments Of Short Term Debt -40706000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Proceeds From Sale Of Restricted Investments 4232000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Retained Earnings Accumulated Deficit 103268000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Retained Earnings Accumulated Deficit 106023000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20231231 Shares Outstanding 3834976.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0001999371-25-005747 20241231 Short Term Borrowings 4088000.0000 USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Over90 Days; Financial Instrument= Other Debt Securities; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20241231 Short Term Borrowings 4088000.0000 USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Over90 Days; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity30 To90 Days; Financial Instrument= U S States And Political Subdivisions; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings 20759000.0000 USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Overnight And On Demand; Financial Instrument= Mortgage Backed Securities; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Overnight And On Demand; Financial Instrument= Other Debt Securities; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings 4737000.0000 USD 0 us-gaap/2025 Financial Instrument= Other Debt Securities; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20241231 Stockholders Equity 166410000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Stockholders Equity 83594000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001999371-25-005747 20240331 Stock Issued During Period Shares Employee Stock Purchase Plans 2012.0000 shares 1 us-gaap/2025 Equity Components= Common Stock;
0001999371-25-005747 20250331 Stock Issued During Period Value Employee Stock Purchase Plan 2000.0000 USD 1 us-gaap/2025 Equity Components= Common Stock;
0001999371-25-005747 20250331 Treasury Stock Common Shares 308725.0000 shares 0 us-gaap/2025
0001999371-25-005747 20240331 Weighted Average Number Of Diluted Shares Outstanding 3570342.0000 shares 1 us-gaap/2025
0001999371-25-005747 20240331 Amortization Of Financing Costs And Discounts -2789000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Amortization Of Intangible Assets 510000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Atm And Interchange Expenses 262000.0000 USD 1 0001999371-25-005747
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities 82762000.0000 USD 0 us-gaap/2025 Financial Instrument= U S States And Political Subdivisions;
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities 176016000.0000 USD 0 us-gaap/2025 Pledged Status= Asset Pledged As Collateral;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities 283000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Debt Securities;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities 106619000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Debt Obligations;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities 283000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Debt Securities;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities 81222000.0000 USD 0 us-gaap/2025 Financial Instrument= U S States And Political Subdivisions;
0001999371-25-005747 20250331 Brokerage Commissions Revenue 233000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Cash And Due From Banks 11200000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20241231 Cash Cash Equivalents And Federal Funds Sold 17380000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Cash Cash Equivalents And Federal Funds Sold 23759000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Debt Securities Available For Sale Gain Loss -8000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Dividends Common Stock Cash USD 1 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001999371-25-005747 20240331 Earnings Per Share Basic 1.1300 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Federal Deposit Insurance Corporation Premium Expense 218000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Federal Home Loan Bank Advances Long Term 50384000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20231231 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 801000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Portfolio Segment;
0001999371-25-005747 20231231 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 180000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Consumer And Other;
0001999371-25-005747 20241231 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 9858000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 9985000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Transfer Of Portfolio Loans And Leases To Held For Sale1 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 1402000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Portfolio Segment;
0001999371-25-005747 20250331 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 2014000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Residential Real Estate;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss 1134199000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 21850000.0000 USD 0 us-gaap/2025 Financial Instrument= Consumer Loan;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 56000.0000 USD 0 us-gaap/2025 Financial Instrument Performance Status= Current Period Gross Charge Offs; Financing Receivable Portfolio Segment= Residential Consumer And Other;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 601000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial; Financing Receivables Period Past Due= Financing Receivables Equal To Greater Than90 Days Past Due;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 93445000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial Portfolio Segment;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 2139000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate; Financing Receivables Period Past Due= Financing Receivables30 To59 Days Past Due;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 465135000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Commercial And Industrial Portfolio Segment;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Portfolio Segment; Internal Credit Assessment= Doubtful;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 638952000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Residential Real Estate;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 625201000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Residential Real Estate; Financing Receivables Period Past Due= Financial Asset Not Past Due;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 1106594000.0000 USD 0 us-gaap/2025 Financing Receivables Period Past Due= Financial Asset Not Past Due;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 19343000.0000 USD 0 us-gaap/2025 Financing Receivables Period Past Due= Financial Asset Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 93932000.0000 USD 0 us-gaap/2025 Financial Instrument= Commercial And Industrial;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 377877000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 123000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate; Financing Receivables Period Past Due= Financing Receivables60 To89 Days Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 11229000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Portfolio Segment; Internal Credit Assessment= Substandard;
0001999371-25-005747 20241231 Treasury Stock Value 11307000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 82000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Consumer And Other; Financing Receivables Period Past Due= Financing Receivables Equal To Greater Than90 Days Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 9797000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Residential Real Estate; Financing Receivables Period Past Due= Financing Receivables30 To59 Days Past Due;
0001999371-25-005747 20250331 Increase Decrease In Deposits 46109000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Interest And Dividend Income Operating 19889000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Interest And Fee Income Loan Tax Exempt 398000.0000 USD 1 0001999371-25-005747
0001999371-25-005747 20241231 Interest Bearing Deposit Liabilities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1;
0001999371-25-005747 20241231 Interest Bearing Deposit Liabilities 347176000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3;
0001999371-25-005747 20241231 Interest Bearing Deposit Liabilities 1032729000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001999371-25-005747 20241231 Interest Bearing Deposits In Banks 6180000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Interest Expense Short Term Borrowings 2497000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Interest Payable Current And Noncurrent USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3;
0001999371-25-005747 20250331 Interest Payable Current And Noncurrent 1864000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20241231 Interest Receivable 4850000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20241231 Loans Receivable Held For Sale Amount 1691000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Noninterest Bearing Deposit Liabilities 273783000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001999371-25-005747 20240331 Noninterest Income 2532000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Other Amortization Of Deferred Charges 97000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Other Assets 5993000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Other Comprehensive Income Loss Net Of Tax USD 1 us-gaap/2025 Equity Components= Common Stock;
0001999371-25-005747 20250331 Other Comprehensive Income Loss Net Of Tax USD 1 us-gaap/2025 Equity Components= Common Stock;
0001999371-25-005747 20240331 Other Comprehensive Income Loss Reclassification Adjustment From A O C I For Sale Of Securities Before Tax -8000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Other Interest And Dividend Income 223000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Other Noncash Income Expense -68000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Other Noninterest Expense 972000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Other Noninterest Expense 892000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Payments For Proceeds From Loans And Leases 9735000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Payments For Proceeds From Loans And Leases 15733000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Payments To Acquire Intangible Assets 18000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Proceeds From Sale Of Mortgage Loans Held For Sale 2257000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Repayments Of Federal Home Loan Bank Borrowings 5001000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Short Term Borrowings 18582000.0000 USD 0 us-gaap/2025 Short Term Debt Type= Other Short Term Borrowings;
0001999371-25-005747 20250331 Short Term Borrowings USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity30 To90 Days; Financial Instrument= Collateralized Debt Obligations; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity30 To90 Days; Financial Instrument= Mortgage Backed Securities; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings 414000.0000 USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Overnight And On Demand; Financial Instrument= Collateralized Debt Obligations; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings 1772000.0000 USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Overnight And On Demand; Financial Instrument= U S States And Political Subdivisions; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Up To30 Days; Financial Instrument= U S States And Political Subdivisions; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings 414000.0000 USD 0 us-gaap/2025 Financial Instrument= Collateralized Debt Obligations; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings 20759000.0000 USD 0 us-gaap/2025 Financial Instrument= Mortgage Backed Securities; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20240331 State Shares Tax Net 210000.0000 USD 1 0001999371-25-005747
0001999371-25-005747 20231231 Stockholders Equity 90514000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0001999371-25-005747 20241231 Stockholders Equity -13896000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001999371-25-005747 20241231 Stockholders Equity 4802000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001999371-25-005747 20250331 Stockholders Equity 4804000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001999371-25-005747 20250331 Stock Issued During Period Shares Employee Stock Purchase Plans 1253.0000 shares 1 us-gaap/2025 Equity Components= Common Stock;
0001999371-25-005747 20240331 Stock Issued During Period Value Employee Stock Purchase Plan USD 1 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001999371-25-005747 20250331 Stock Issued During Period Value Employee Stock Purchase Plan USD 1 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001999371-25-005747 20250331 Stock Issued During Period Value Employee Stock Purchase Plan 46000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001999371-25-005747 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2025 Equity Components= Treasury Stock Common;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 3680000.0000 USD 0 us-gaap/2025 Financing Receivables Period Past Due= Financing Receivables60 To89 Days Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 332339000.0000 USD 0 us-gaap/2025 Financial Instrument= Commercial Loan;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 672375000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Residential Consumer And Other;
0001999371-25-005747 20250331 Finite Lived Intangible Assets Net 9555000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Increase Decrease In Accrued Interest Receivable Net 1030000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Increase Decrease In Deposits 62350000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Interest And Fee Income Loan Tax Exempt 353000.0000 USD 1 0001999371-25-005747
0001999371-25-005747 20240331 Interest Income Deposits With Financial Institutions 66000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Interest Income Expense Net 11935000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Interest Income Expense Net 13868000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Interest Payable Current And Noncurrent 1857000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Net Cash Provided By Used In Financing Activities -70784000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Net Cash Provided By Used In Financing Activities -1363000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Net Income Loss 4036000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Net Income Loss USD 1 us-gaap/2025 Equity Components= Treasury Stock Common;
0001999371-25-005747 20241231 Noninterest Bearing Deposit Liabilities 259700000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Noninterest Expense 9646000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Non Interest Income Interchange Fees 619000.0000 USD 1 0001999371-25-005747
0001999371-25-005747 20240331 Other Comprehensive Income Loss Net Of Tax USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001999371-25-005747 20240331 Other Comprehensive Income Loss Net Of Tax USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001999371-25-005747 20250331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax 579000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Payments Of Dividends Common Stock 1590000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities 21688000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities 18771000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Proceeds From Sale Of Available For Sale Securities Debt 50311000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Property Plant And Equipment Net 26644000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Provision For Loan Lease And Other Losses 110000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Service Charges And Fees Income 722000.0000 USD 1 0001999371-25-005747
0001999371-25-005747 20241231 Short Term Borrowings 68388000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20241231 Short Term Borrowings 45118000.0000 USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Overnight And On Demand; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20241231 Short Term Borrowings 600000.0000 USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Up To30 Days; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings 27682000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Short Term Borrowings USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Over90 Days; Financial Instrument= Mortgage Backed Securities; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Up To30 Days; Financial Instrument= Mortgage Backed Securities; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings 1579000.0000 USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Up To30 Days; Financial Instrument= Other Debt Securities; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings USD 0 us-gaap/2025 Short Term Debt Type= Other Short Term Borrowings;
0001999371-25-005747 20250331 Short Term Borrowings 27682000.0000 USD 0 us-gaap/2025 Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20240331 Stock Issued During Period Value Employee Stock Purchase Plan USD 1 us-gaap/2025 Equity Components= Treasury Stock Common;
0001999371-25-005747 20250331 Stock Issued During Period Value Employee Stock Purchase Plan USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001999371-25-005747 20240331 Transfer Of Portfolio Loans And Leases To Held For Sale1 165000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities 7046000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Collateralized Debt Obligations;
0001999371-25-005747 20240331 Accretion Amortization Of Discounts And Premiums Investments 184000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Accretion Amortization Of Discounts And Premiums Investments 221000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax -11714000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 6000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001999371-25-005747 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001999371-25-005747 20240331 Amortization Of Investment In Limited Partnerships 187000.0000 USD 1 0001999371-25-005747
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities 323248000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities 82762000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities 113707000.0000 USD 0 us-gaap/2025 Financial Instrument= Mortgage Backed Securities;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Debt Securities;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities 6923000.0000 USD 0 us-gaap/2025 Financial Instrument= Collateralized Debt Obligations;
0001999371-25-005747 20250331 Bank Owned Life Insurance 41204000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Bank Owned Life Insurance Income 231000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Common Stock Shares Outstanding 3532713.0000 shares 0 us-gaap/2025
0001999371-25-005747 20240331 Communication 920000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Equipment Expense 426000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Equity Securities Fv Ni Gain Loss -117000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 208000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Consumer And Other;
0001999371-25-005747 20250331 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 1402000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial;
0001999371-25-005747 20250331 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 160000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Consumer And Other;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 93445000.0000 USD 0 us-gaap/2025 Financial Instrument= Commercial And Industrial;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 11000.0000 USD 0 us-gaap/2025 Financial Instrument Performance Status= Current Period Gross Charge Offs; Financing Receivable Portfolio Segment= Consumer And Other;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 755000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial; Financing Receivables Period Past Due= Financial Asset Past Due;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 371690000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 1115000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate; Financing Receivables Period Past Due= Financing Receivables60 To89 Days Past Due;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 67000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Consumer And Other; Financing Receivables Period Past Due= Financing Receivables Equal To Greater Than90 Days Past Due;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 7163000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Residential Real Estate; Financing Receivables Period Past Due= Financing Receivables30 To59 Days Past Due;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 4262000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Residential Real Estate; Financing Receivables Period Past Due= Financing Receivables Equal To Greater Than90 Days Past Due;
0001999371-25-005747 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2025 Equity Components= Common Stock;
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities 113707000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mortgage Backed Securities;
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities 113707000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mortgage Backed Securities;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities 307459000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Collateralized Debt Obligations;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Debt Obligations;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities 106619000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Debt Obligations;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities 6923000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Collateralized Debt Obligations;
0001999371-25-005747 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -2146000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Common Stock Shares Issued 3841438.0000 shares 0 us-gaap/2025
0001999371-25-005747 20250331 Common Stock Value 4804000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Depreciation Nonproduction 370000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Dividends Common Stock Cash USD 1 us-gaap/2025 Equity Components= Treasury Stock Common;
0001999371-25-005747 20240331 Fees And Commissions Fiduciary And Trust Activities 206000.0000 USD 1 0001999371-25-005747
0001999371-25-005747 20231231 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 6847000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Portfolio Segment;
0001999371-25-005747 20240331 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 411000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Consumer And Other;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss 1116079000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 632017000.0000 USD 0 us-gaap/2025 Financial Instrument Performance Status= Performing Financing Receivable; Financing Receivable Portfolio Segment= Residential Portfolio Segment;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 111000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial; Financing Receivables Period Past Due= Financing Receivables60 To89 Days Past Due;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial Portfolio Segment; Internal Credit Assessment= Doubtful;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 932000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial Portfolio Segment; Internal Credit Assessment= Special Mention;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 7436000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Commercial And Industrial Portfolio Segment; Internal Credit Assessment= Special Mention;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 318000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Consumer And Other; Financing Receivables Period Past Due= Financial Asset Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 20611000.0000 USD 0 us-gaap/2025 Financial Instrument Performance Status= Performing Financing Receivable; Financing Receivable Portfolio Segment= Consumer And Other;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 665200000.0000 USD 0 us-gaap/2025 Financial Instrument Performance Status= Performing Financing Receivable; Financing Receivable Portfolio Segment= Residential Consumer And Other;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial; Financing Receivables Period Past Due= Financing Receivables60 To89 Days Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 471809000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Commercial And Industrial Portfolio Segment;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 20836000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Consumer And Other;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 20674000.0000 USD 0 us-gaap/2025 Financing Receivables Period Past Due= Financial Asset Past Due;
0001999371-25-005747 20240331 Increase Decrease In Interest Payable Net 1166000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Interest And Fee Income Loan Taxable 17256000.0000 USD 1 0001999371-25-005747
0001999371-25-005747 20250331 Interest And Fee Income Loan Taxable 18284000.0000 USD 1 0001999371-25-005747
0001999371-25-005747 20250331 Interest Bearing Deposit Liabilities 1064852000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001999371-25-005747 20250331 Interest Expense Short Term Borrowings 543000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Interest Receivable 4948000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2;
0001999371-25-005747 20241231 Investments In Affiliates Subsidiaries Associates And Joint Ventures 5092000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20241231 Liabilities 1429548000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Net Income Loss 4036000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001999371-25-005747 20241231 Noninterest Bearing Deposit Liabilities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1;
0001999371-25-005747 20241231 Noninterest Bearing Deposit Liabilities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3;
0001999371-25-005747 20241231 Noninterest Bearing Deposit Liabilities 259700000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001999371-25-005747 20250331 Noninterest Bearing Deposit Liabilities 273783000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001999371-25-005747 20250331 Noninterest Expense 11091000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Occupancy Net 618000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Occupancy Net 720000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Other Comprehensive Income Loss Net Of Tax 2182000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax 2761000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Payments To Acquire Life Insurance Policies 20000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Payments To Acquire Property Plant And Equipment 576000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Payments To Acquire Restricted Investments 1851000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Payments To Acquire Restricted Investments 1613000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Proceeds From Issuance Of Common Stock 56000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Proceeds From Sale Of Mortgage Loans Held For Sale 3675000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Proceeds From Sale Of Restricted Investments 2228000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Professional Fees 448000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Property Plant And Equipment Net 26484000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20241231 Restricted Investments 7095000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20241231 Short Term Borrowings USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity30 To90 Days; Financial Instrument= Other Debt Securities; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20241231 Short Term Borrowings USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Over90 Days; Financial Instrument= Mortgage Backed Securities; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20241231 Short Term Borrowings USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Over90 Days; Financial Instrument= U S States And Political Subdivisions; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20241231 Short Term Borrowings 628000.0000 USD 0 us-gaap/2025 Financial Instrument= Collateralized Debt Obligations; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20241231 Short Term Borrowings 49806000.0000 USD 0 us-gaap/2025 Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Up To30 Days; Financial Instrument= Collateralized Debt Obligations; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings 1579000.0000 USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Up To30 Days; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 State Shares Tax Net 301000.0000 USD 1 0001999371-25-005747
0001999371-25-005747 20231231 Stockholders Equity -15036000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001999371-25-005747 20231231 Stockholders Equity 83343000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001999371-25-005747 20240331 Stockholders Equity 4796000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001999371-25-005747 20250331 Stockholders Equity 106023000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0001999371-25-005747 20250331 Stockholders Equity -11307000.0000 USD 0 us-gaap/2025 Equity Components= Treasury Stock Common;
0001999371-25-005747 20241231 Treasury Stock Common Shares 308725.0000 shares 0 us-gaap/2025
0001999371-25-005747 20240331 Weighted Average Number Of Shares Outstanding Basic 3570342.0000 shares 1 us-gaap/2025
0001999371-25-005747 20250331 Weighted Average Number Of Shares Outstanding Basic 3532727.0000 shares 1 us-gaap/2025
0001999371-25-005747 20241231 Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax -13896000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20241231 Additional Paid In Capital Common Stock 83543000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 6000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001999371-25-005747 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2025 Equity Components= Treasury Stock Common;
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities 7046000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Collateralized Debt Obligations;
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Debt Obligations;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities 307459000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities 81222000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0001999371-25-005747 20240331 Bank Owned Life Insurance Income 227000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Brokerage Commissions Revenue 224000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 23759000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 6379000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Common Stock Par Or Stated Value Per Share 1.2500 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Common Stock Shares Outstanding 3533966.0000 shares 0 us-gaap/2025
0001999371-25-005747 20250331 Comprehensive Income Net Of Tax 6527000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Deferred Income Tax Assets Net 10012000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Deferred Income Tax Assets Net 9213000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Deferred Income Tax Expense Benefit 1284000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Earnings Per Share Diluted 1.2300 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Equity Securities Fv Ni Current And Noncurrent 1321000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Equity Securities Fv Ni Gain Loss -34000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Fees And Commissions Fiduciary And Trust Activities 238000.0000 USD 1 0001999371-25-005747
0001999371-25-005747 20231231 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 1474000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Residential Portfolio Segment;
0001999371-25-005747 20240331 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 712000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Portfolio Segment;
0001999371-25-005747 20250331 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 6409000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Portfolio Segment;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 1125937000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 4111000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial Portfolio Segment; Internal Credit Assessment= Substandard;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 21850000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Consumer And Other;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 128000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Consumer And Other; Financing Receivables Period Past Due= Financing Receivables60 To89 Days Past Due;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 638952000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Residential Portfolio Segment;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 1000.0000 USD 0 us-gaap/2025 Financial Instrument Performance Status= Current Period Gross Charge Offs; Financing Receivable Portfolio Segment= Residential Consumer And Other;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 225000.0000 USD 0 us-gaap/2025 Financial Instrument Performance Status= Nonperforming Financing Receivable; Financing Receivable Portfolio Segment= Consumer And Other;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 644589000.0000 USD 0 us-gaap/2025 Financial Instrument Performance Status= Performing Financing Receivable; Financing Receivable Portfolio Segment= Residential Portfolio Segment;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial Portfolio Segment; Internal Credit Assessment= Doubtful;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 4700000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate; Financing Receivables Period Past Due= Financial Asset Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Commercial And Industrial Portfolio Segment; Internal Credit Assessment= Doubtful;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 377877000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Portfolio Segment;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Portfolio Segment; Internal Credit Assessment= Doubtful;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 348000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Consumer And Other; Financing Receivables Period Past Due= Financial Asset Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 651539000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Residential Portfolio Segment;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 2182000.0000 USD 0 us-gaap/2025 Financing Receivables Period Past Due= Financing Receivables60 To89 Days Past Due;
0001999371-25-005747 20250331 Foreclosed Assets 70000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20241231 Goodwill 25609000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 4731000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Increase Decrease In Accrued Interest Receivable Net -707000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Interest Bearing Deposit Liabilities 1032729000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20241231 Interest Bearing Deposit Liabilities 684022000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2;
0001999371-25-005747 20250331 Interest Expense Deposits 5801000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term 847000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Interest Income Securities Tax Exempt 830000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Interest Income Securities Tax Exempt 860000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Interest Payable Current And Noncurrent USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3;
0001999371-25-005747 20241231 Interest Receivable 4850000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001999371-25-005747 20250331 Interest Receivable USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1;
0001999371-25-005747 20250331 Investments In Affiliates Subsidiaries Associates And Joint Ventures 4905000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Net Income Loss USD 1 us-gaap/2025 Equity Components= Treasury Stock Common;
0001999371-25-005747 20240331 Noncash Merger Related Costs 96000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Noninterest Bearing Deposit Liabilities 259700000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001999371-25-005747 20250331 Noninterest Expense Directors Fees 153000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Non Interest Income Interchange Fees 623000.0000 USD 1 0001999371-25-005747
0001999371-25-005747 20250331 Other Assets 5188000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Other Comprehensive Income Loss Net Of Tax -1490000.0000 USD 1 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001999371-25-005747 20250331 Other Comprehensive Income Loss Net Of Tax 2182000.0000 USD 1 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001999371-25-005747 20250331 Other Comprehensive Income Loss Net Of Tax USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001999371-25-005747 20250331 Other Comprehensive Income Loss Net Of Tax USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001999371-25-005747 20240331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax -397000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Other Interest And Dividend Income 168000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Payments For Origination Of Mortgage Loans Held For Sale 2429000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Payments Of Dividends Common Stock 1570000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Payments To Acquire Intangible Assets USD 1 us-gaap/2025
0001999371-25-005747 20250331 Proceeds From Issuance Of Common Stock 48000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Proceeds From Other Deposits USD 1 us-gaap/2025
0001999371-25-005747 20240331 Provision For Loan Lease And Other Losses 90000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Repayments Of Federal Home Loan Bank Borrowings 5224000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Restricted Investments 6480000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Salaries Wages And Officers Compensation 4802000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Service Charges And Fees Income 615000.0000 USD 1 0001999371-25-005747
0001999371-25-005747 20250331 Shares Outstanding 3842691.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0001999371-25-005747 20241231 Short Term Borrowings USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity30 To90 Days; Financial Instrument= Mortgage Backed Securities; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20241231 Short Term Borrowings USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Over90 Days; Financial Instrument= Collateralized Debt Obligations; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20241231 Short Term Borrowings 4511000.0000 USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Overnight And On Demand; Financial Instrument= Other Debt Securities; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20241231 Short Term Borrowings 2594000.0000 USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Overnight And On Demand; Financial Instrument= U S States And Political Subdivisions; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings 1772000.0000 USD 0 us-gaap/2025 Financial Instrument= U S States And Political Subdivisions; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20241231 Stockholders Equity -11307000.0000 USD 0 us-gaap/2025 Equity Components= Treasury Stock Common;
0001999371-25-005747 20240331 Stock Issued During Period Value Employee Stock Purchase Plan USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001999371-25-005747 20250331 Stock Issued During Period Value Employee Stock Purchase Plan USD 1 us-gaap/2025 Equity Components= Treasury Stock Common;
0001999371-25-005747 20250331 Treasury Stock Value 11307000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Weighted Average Number Of Diluted Shares Outstanding 3532727.0000 shares 1 us-gaap/2025
0001999371-25-005747 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001999371-25-005747 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value USD 1 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001999371-25-005747 20241231 Assets 1595958000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Collateralized Debt Obligations;
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities 82762000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mortgage Backed Securities;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities 81222000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001999371-25-005747 20241231 Bank Owned Life Insurance 40953000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Common Stock Dividends Per Share Cash Paid 0.4500 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Deferred Income Tax Expense Benefit 220000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Dividends Common Stock Cash 1570000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Dividends Common Stock Cash USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001999371-25-005747 20240331 Federal Deposit Insurance Corporation Premium Expense 220000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20231231 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 9302000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 7166000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Portfolio Segment;
0001999371-25-005747 20240331 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 1062000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Residential Portfolio Segment;
0001999371-25-005747 20250331 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 2014000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Residential Portfolio Segment;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 653698000.0000 USD 0 us-gaap/2025 Financial Instrument Performance Status= Performing Financing Receivable; Financing Receivable Portfolio Segment= Residential Consumer And Other;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 92690000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial; Financing Receivables Period Past Due= Financial Asset Not Past Due;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 4519000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate; Financing Receivables Period Past Due= Financial Asset Past Due;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 444272000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Commercial And Industrial Portfolio Segment; Internal Credit Assessment= Pass;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 13427000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Commercial And Industrial Portfolio Segment; Internal Credit Assessment= Substandard;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 355870000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Portfolio Segment; Internal Credit Assessment= Pass;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 21532000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Consumer And Other; Financing Receivables Period Past Due= Financial Asset Not Past Due;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 9468000.0000 USD 0 us-gaap/2025 Financing Receivables Period Past Due= Financing Receivables30 To59 Days Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 45538000.0000 USD 0 us-gaap/2025 Financial Instrument= Student Housing;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 1000.0000 USD 0 us-gaap/2025 Financial Instrument Performance Status= Current Period Gross Charge Offs; Financing Receivable Portfolio Segment= Consumer And Other;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 88907000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial Portfolio Segment; Internal Credit Assessment= Pass;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 5000000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial Portfolio Segment; Internal Credit Assessment= Substandard;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 2713000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate; Financing Receivables Period Past Due= Financing Receivables Equal To Greater Than90 Days Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 16229000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Commercial And Industrial Portfolio Segment; Internal Credit Assessment= Substandard;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 20488000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Consumer And Other; Financing Receivables Period Past Due= Financial Asset Not Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 140000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Consumer And Other; Financing Receivables Period Past Due= Financing Receivables30 To59 Days Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 651539000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Residential Real Estate;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 14764000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Residential Real Estate; Financing Receivables Period Past Due= Financial Asset Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 1933000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Residential Real Estate; Financing Receivables Period Past Due= Financing Receivables60 To89 Days Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 3034000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Residential Real Estate; Financing Receivables Period Past Due= Financing Receivables Equal To Greater Than90 Days Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 6665000.0000 USD 0 us-gaap/2025 Financing Receivables Period Past Due= Financing Receivables Equal To Greater Than90 Days Past Due;
0001999371-25-005747 20250331 Gain Loss On Sales Of Loans Net 83000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Interest And Dividend Income Operating 20841000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Interest Bearing Deposit Liabilities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1;
0001999371-25-005747 20240331 Interest Income Expense After Provision For Loan Loss 11845000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Interest Paid Net 8031000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Interest Receivable 4850000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001999371-25-005747 20250331 Interest Receivable 4948000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Interest Receivable 4948000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001999371-25-005747 20250331 Net Cash Provided By Used In Investing Activities 3039000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Net Cash Provided By Used In Operating Activities 4703000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Net Income Loss USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001999371-25-005747 20240331 Noninterest Expense Directors Fees 134000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Other Comprehensive Income Loss Reclassification Adjustment From A O C I For Sale Of Securities Tax -2000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Other Comprehensive Income Loss Reclassification Adjustment From A O C I For Sale Of Securities Tax USD 1 us-gaap/2025
0001999371-25-005747 20240331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax -1893000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Other Liabilities 12371000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Payments For Origination Of Mortgage Loans Held For Sale 3683000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Payments To Acquire Life Insurance Policies 20000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Proceeds From Sale Of Available For Sale Securities Debt USD 1 us-gaap/2025
0001999371-25-005747 20240331 Professional Fees 457000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Short Term Borrowings USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity30 To90 Days; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20241231 Short Term Borrowings 628000.0000 USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Overnight And On Demand; Financial Instrument= Collateralized Debt Obligations; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20241231 Short Term Borrowings 37385000.0000 USD 0 us-gaap/2025 Financial Instrument= Mortgage Backed Securities; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20241231 Short Term Borrowings 9199000.0000 USD 0 us-gaap/2025 Financial Instrument= Other Debt Securities; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings 3158000.0000 USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Over90 Days; Financial Instrument= Other Debt Securities; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Over90 Days; Financial Instrument= U S States And Political Subdivisions; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings 3158000.0000 USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Over90 Days; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings 22945000.0000 USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Overnight And On Demand; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20240331 Stockholders Equity 154863000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Stock Issued During Period Value Employee Stock Purchase Plan 54000.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001999371-25-005747 20250331 Interest Expense Operating 6973000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Interest Income Securities Taxable 1161000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Additional Paid In Capital Common Stock 83594000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Amortization Of Financing Costs And Discounts -2497000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Amortization Of Intangible Assets 549000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Assets 1602336000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Atm And Interchange Expenses 264000.0000 USD 1 0001999371-25-005747
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities 323248000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities 119454000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Debt Obligations;
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Debt Securities;
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities 7046000.0000 USD 0 us-gaap/2025 Financial Instrument= Collateralized Debt Obligations;
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities 119454000.0000 USD 0 us-gaap/2025 Financial Instrument= Other Debt Securities;
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities 279000.0000 USD 0 us-gaap/2025 Financial Instrument= Other Securities;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities 307459000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities 112412000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mortgage Backed Securities;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities 112412000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mortgage Backed Securities;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities 112412000.0000 USD 0 us-gaap/2025 Financial Instrument= Mortgage Backed Securities;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities 283000.0000 USD 0 us-gaap/2025 Financial Instrument= Other Securities;
0001999371-25-005747 20250331 Common Stock Par Or Stated Value Per Share 1.2500 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Common Stock Shares Issued 3842691.0000 shares 0 us-gaap/2025
0001999371-25-005747 20250331 Debt Securities Available For Sale Gain Loss USD 1 us-gaap/2025
0001999371-25-005747 20240331 Debt Securities Available For Sale Realized Gain Loss -8000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Deposits 1292429000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Deposits 1338635000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Dividends Common Stock Cash USD 1 us-gaap/2025 Equity Components= Common Stock;
0001999371-25-005747 20250331 Dividends Common Stock Cash USD 1 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001999371-25-005747 20250331 Dividends Common Stock Cash USD 1 us-gaap/2025 Equity Components= Common Stock;
0001999371-25-005747 20250331 Interest Income Securities Taxable 1097000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Dividends Common Stock Cash 1590000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001999371-25-005747 20241231 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 931000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial;
0001999371-25-005747 20241231 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 1850000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Residential Real Estate;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 45808000.0000 USD 0 us-gaap/2025 Financial Instrument= Student Housing;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 45000.0000 USD 0 us-gaap/2025 Financial Instrument Performance Status= Current Period Gross Charge Offs; Financing Receivable Portfolio Segment= Residential Portfolio Segment;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 7105000.0000 USD 0 us-gaap/2025 Financial Instrument Performance Status= Nonperforming Financing Receivable; Financing Receivable Portfolio Segment= Residential Consumer And Other;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 6936000.0000 USD 0 us-gaap/2025 Financial Instrument Performance Status= Nonperforming Financing Receivable; Financing Receivable Portfolio Segment= Residential Portfolio Segment;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 93445000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 43000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial; Financing Receivables Period Past Due= Financing Receivables30 To59 Days Past Due;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Commercial And Industrial Portfolio Segment; Internal Credit Assessment= Doubtful;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 371690000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Portfolio Segment;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 20836000.0000 USD 0 us-gaap/2025 Financial Instrument= Consumer Loan;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 651539000.0000 USD 0 us-gaap/2025 Financial Instrument= Residential Real Estate;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss USD 0 us-gaap/2025 Financial Instrument Performance Status= Current Period Gross Charge Offs; Financing Receivable Portfolio Segment= Residential Portfolio Segment;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 7175000.0000 USD 0 us-gaap/2025 Financial Instrument Performance Status= Nonperforming Financing Receivable; Financing Receivable Portfolio Segment= Residential Consumer And Other;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 360795000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Portfolio Segment; Internal Credit Assessment= Pass;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 5853000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Portfolio Segment; Internal Credit Assessment= Special Mention;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 126000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Consumer And Other; Financing Receivables Period Past Due= Financing Receivables60 To89 Days Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 1123510000.0000 USD 0 us-gaap/2025 Financing Receivables Period Past Due= Financial Asset Not Past Due;
0001999371-25-005747 20241231 Finite Lived Intangible Assets Net 10047000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20241231 Foreclosed Assets 70000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Gain Loss On Sales Of Loans Net 76000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Gains Losses On Sales Of Other Real Estate USD 1 us-gaap/2025
0001999371-25-005747 20250331 Goodwill 25609000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 5112000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Income Tax Expense Benefit 767000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Interest Bearing Deposit Liabilities 705836000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2;
0001999371-25-005747 20250331 Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term 629000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Interest Payable Current And Noncurrent 1857000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001999371-25-005747 20250331 Interest Payable Current And Noncurrent USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1;
0001999371-25-005747 20250331 Interest Payable Current And Noncurrent 1864000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001999371-25-005747 20250331 Liabilities 1430936000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20241231 Liabilities And Stockholders Equity 1595958000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Net Income Loss USD 1 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001999371-25-005747 20250331 Net Income Loss 4345000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Net Income Loss USD 1 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001999371-25-005747 20250331 Noninterest Bearing Deposit Liabilities 273783000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2;
0001999371-25-005747 20250331 Noninterest Income 2445000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Noninterest Income Other Operating Income 349000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Other Comprehensive Income Loss Reclassification Adjustment From A O C I For Sale Of Securities Before Tax USD 1 us-gaap/2025
0001999371-25-005747 20241231 Other Liabilities 11338000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Payments To Acquire Property Plant And Equipment 113000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Salaries Wages And Officers Compensation 6320000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Shares Outstanding 3841438.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0001999371-25-005747 20241231 Short Term Borrowings USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Up To30 Days; Financial Instrument= Collateralized Debt Obligations; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20241231 Short Term Borrowings USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Up To30 Days; Financial Instrument= Mortgage Backed Securities; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20241231 Short Term Borrowings 2594000.0000 USD 0 us-gaap/2025 Financial Instrument= U S States And Political Subdivisions; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity30 To90 Days; Financial Instrument= Other Debt Securities; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20231231 Stockholders Equity 153825000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20231231 Stockholders Equity -9790000.0000 USD 0 us-gaap/2025 Equity Components= Treasury Stock Common;
0001999371-25-005747 20240331 Stockholders Equity 83403000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001999371-25-005747 20240331 Stockholders Equity 92980000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0001999371-25-005747 20240331 Stockholders Equity -9790000.0000 USD 0 us-gaap/2025 Equity Components= Treasury Stock Common;
0001999371-25-005747 20241231 Stockholders Equity 103268000.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0001999371-25-005747 20250331 Stockholders Equity 171400000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Stockholders Equity -11714000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001999371-25-005747 20240331 Stock Issued During Period Value Employee Stock Purchase Plan 56000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Stock Issued During Period Value Employee Stock Purchase Plan 48000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mortgage Backed Securities;
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities 279000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Debt Securities;
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001999371-25-005747 20241231 Available For Sale Securities Debt Securities 119454000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Debt Obligations;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Other Debt Securities;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities 6923000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Collateralized Debt Obligations;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Collateralized Debt Obligations;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Mortgage Backed Securities;
0001999371-25-005747 20250331 Available For Sale Securities Debt Securities 153283000.0000 USD 0 us-gaap/2025 Pledged Status= Asset Pledged As Collateral;
0001999371-25-005747 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 18377000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 17380000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20241231 Common Stock Shares Authorized 15000000.0000 shares 0 us-gaap/2025
0001999371-25-005747 20240331 Comprehensive Income Net Of Tax 2546000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Dividends Common Stock Cash USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001999371-25-005747 20240331 Dividends Common Stock Cash 1570000.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001999371-25-005747 20240331 Earnings Per Share Diluted 1.1300 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Federal Home Loan Bank Advances Long Term 55536000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 9351000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20241231 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 6869000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate;
0001999371-25-005747 20241231 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 6869000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Portfolio Segment;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 325882000.0000 USD 0 us-gaap/2025 Financial Instrument= Commercial Loan;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 638952000.0000 USD 0 us-gaap/2025 Financial Instrument= Residential Real Estate;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 88402000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial Portfolio Segment; Internal Credit Assessment= Pass;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 367171000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate; Financing Receivables Period Past Due= Financial Asset Not Past Due;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 1265000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate; Financing Receivables Period Past Due= Financing Receivables Equal To Greater Than90 Days Past Due;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 6504000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Portfolio Segment; Internal Credit Assessment= Special Mention;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 123000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Consumer And Other; Financing Receivables Period Past Due= Financing Receivables30 To59 Days Past Due;
0001999371-25-005747 20241231 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 13751000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Residential Real Estate; Financing Receivables Period Past Due= Financial Asset Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 1144184000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 93932000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 862000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial; Financing Receivables Period Past Due= Financial Asset Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 26000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial And Industrial; Financing Receivables Period Past Due= Financing Receivables30 To59 Days Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 1864000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate; Financing Receivables Period Past Due= Financing Receivables30 To59 Days Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 449702000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Commercial Real Estate Commercial And Industrial Portfolio Segment; Internal Credit Assessment= Pass;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 636775000.0000 USD 0 us-gaap/2025 Financing Receivable Portfolio Segment= Residential Real Estate; Financing Receivables Period Past Due= Financial Asset Not Past Due;
0001999371-25-005747 20250331 Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss 11827000.0000 USD 0 us-gaap/2025 Financing Receivables Period Past Due= Financing Receivables30 To59 Days Past Due;
0001999371-25-005747 20240331 Income Tax Expense Benefit 695000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Increase Decrease In Interest Payable Net 1040000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Interest Bearing Deposit Liabilities 1031198000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001999371-25-005747 20250331 Interest Bearing Deposit Liabilities 1063047000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001999371-25-005747 20240331 Interest Expense Deposits 4610000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Interest Expense Operating 7954000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Interest Income Deposits With Financial Institutions 34000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20250331 Interest Paid Net 6966000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20241231 Interest Payable Current And Noncurrent 1857000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001999371-25-005747 20250331 Interest Payable Current And Noncurrent 1864000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001999371-25-005747 20241231 Interest Receivable 4850000.0000 USD 0 us-gaap/2025 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2;
0001999371-25-005747 20250331 Interest Receivable 4948000.0000 USD 0 us-gaap/2025 Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001999371-25-005747 20250331 Liabilities And Stockholders Equity 1602336000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Net Income Loss USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001999371-25-005747 20250331 Net Income Loss USD 1 us-gaap/2025 Equity Components= Common Stock;
0001999371-25-005747 20250331 Noninterest Bearing Deposit Liabilities 273783000.0000 USD 0 us-gaap/2025
0001999371-25-005747 20240331 Other Amortization Of Deferred Charges 481000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Other Comprehensive Income Loss Net Of Tax USD 1 us-gaap/2025 Equity Components= Treasury Stock Common;
0001999371-25-005747 20250331 Other Noncash Income Expense -72000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Proceeds From Repayments Of Short Term Debt -126619000.0000 USD 1 us-gaap/2025
0001999371-25-005747 20240331 Shares Outstanding 3836988.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0001999371-25-005747 20241231 Short Term Borrowings USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity30 To90 Days; Financial Instrument= Collateralized Debt Obligations; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20241231 Short Term Borrowings USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity30 To90 Days; Financial Instrument= U S States And Political Subdivisions; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20241231 Short Term Borrowings 37385000.0000 USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Overnight And On Demand; Financial Instrument= Mortgage Backed Securities; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20241231 Short Term Borrowings 600000.0000 USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Up To30 Days; Financial Instrument= Other Debt Securities; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20241231 Short Term Borrowings USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Up To30 Days; Financial Instrument= U S States And Political Subdivisions; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity30 To90 Days; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20250331 Short Term Borrowings USD 0 us-gaap/2025 Assets Sold Under Agreements To Repurchase Maturity Periods= Maturity Over90 Days; Financial Instrument= Collateralized Debt Obligations; Short Term Debt Type= Securities Sold Under Agreements To Repurchase;
0001999371-25-005747 20231231 Stockholders Equity 4794000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001999371-25-005747 20240331 Stockholders Equity -16526000.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001999371-25-005747 20241231 Stockholders Equity 83543000.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001999371-25-005747 20240331 Stock Issued During Period Value Employee Stock Purchase Plan 2000.0000 USD 1 us-gaap/2025 Equity Components= Common Stock;

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Equity Securities Fv Ni Current And Noncurrent us-gaap/2025 0 0 monetary I D Equity Securities, FV-NI Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).
Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss us-gaap/2025 0 0 monetary I D Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss Amortized cost excluding accrued interest, before allowance for credit loss, of financing receivable. Excludes net investment in lease.
Deferred Income Tax Assets Net us-gaap/2025 0 0 monetary I D Deferred Income Tax Assets, Net Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Net Cash Provided By Used In Investing Activities us-gaap/2025 0 0 monetary D D Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.
Common Stock Shares Authorized us-gaap/2025 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Earnings Per Share Diluted us-gaap/2025 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Interest Bearing Deposit Liabilities us-gaap/2025 0 0 monetary I C Interest-Bearing Deposit Liabilities The aggregate of all domestic and foreign interest-bearing deposit liabilities.
Professional Fees us-gaap/2025 0 0 monetary D D Professional Fees A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.
Proceeds From Issuance Of Common Stock us-gaap/2025 0 0 monetary D D Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity.
Property Plant And Equipment Net us-gaap/2025 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2025 0 0 monetary D D Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Interest Income Expense Net us-gaap/2025 0 0 monetary D C Interest Income (Expense), Operating Amount of interest income (expense) classified as operating.
Cash And Due From Banks us-gaap/2025 0 0 monetary I D Cash and Due from Banks For banks and other depository institutions: Includes cash on hand (currency and coin), cash items in process of collection, noninterest bearing deposits due from other financial institutions (including corporate credit unions), and noninterest bearing balances with the Federal Reserve Banks, Federal Home Loan Banks and central banks.
Increase Decrease In Interest Payable Net us-gaap/2025 0 0 monetary D D Increase (Decrease) in Interest Payable, Net The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.
Interest Bearing Deposits In Banks us-gaap/2025 0 0 monetary I D Interest-Bearing Deposits in Banks and Other Financial Institutions For banks and other depository institutions (including Federal Reserve Banks, if applicable): Interest-bearing deposits in other financial institutions for relatively short periods of time including, for example, certificates of deposits, which are presented separately from cash on the balance sheet.
Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax us-gaap/2025 0 0 monetary I C AOCI, Debt Securities, Available-for-Sale, Adjustment, after Tax Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2025 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Payments To Acquire Intangible Assets us-gaap/2025 0 0 monetary D C Payments to Acquire Intangible Assets The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.
Bank Owned Life Insurance us-gaap/2025 0 0 monetary I D Bank Owned Life Insurance The carrying amount of a life insurance policy on an officer, executive or employee for which the reporting entity (a bank) is entitled to proceeds from the policy upon death of the insured or surrender of the insurance policy.
Common Stock Shares Issued us-gaap/2025 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Equity Securities Fv Ni Gain Loss us-gaap/2025 0 0 monetary D C Equity Securities, FV-NI, Gain (Loss) Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).
Noninterest Expense us-gaap/2025 0 0 monetary D D Noninterest Expense Total aggregate amount of all noninterest expense.
Noninterest Income Other Operating Income us-gaap/2025 0 0 monetary D C Noninterest Income, Other Operating Income Amount of revenue earned, classified as other, excluding interest income.
Finite Lived Intangible Assets Net us-gaap/2025 0 0 monetary I D Finite-Lived Intangible Assets, Net Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
Comprehensive Income Net Of Tax us-gaap/2025 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2025 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Amortization Of Intangible Assets us-gaap/2025 0 0 monetary D D Amortization of Intangible Assets The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets.
Available For Sale Securities Debt Securities us-gaap/2025 0 0 monetary I D Debt Securities, Available-for-Sale Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Bank Owned Life Insurance Income us-gaap/2025 0 0 monetary D C Bank Owned Life Insurance Income Earnings on or other increases in the value of the cash surrender value of bank owned life insurance policies.
Debt Securities Available For Sale Realized Gain Loss us-gaap/2025 0 0 monetary D C Debt Securities, Available-for-Sale, Realized Gain (Loss) Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Deposits us-gaap/2025 0 0 monetary I C Deposits The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others.
Depreciation Nonproduction us-gaap/2025 0 0 monetary D D Depreciation, Nonproduction The expense recognized in the current period that allocates the cost of nonproduction tangible assets over their useful lives.
Gain Loss On Sales Of Loans Net us-gaap/2025 0 0 monetary D C Gain (Loss) on Sales of Loans, Net The net gain (loss) resulting from a sale of loans, including adjustments to record loans classified as held-for-sale at the lower-of-cost-or-market and fair value adjustments to loan held for investment purposes.
Gains Losses On Sales Of Other Real Estate us-gaap/2025 0 0 monetary D C Gains (Losses) on Sales of Other Real Estate The net gain (loss) resulting from sales and other disposals of other real estate owned, increases (decreases) in the valuation allowance for foreclosed real estate, and write-downs of other real estate owned after acquisition or physical possession.
Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term us-gaap/2025 0 0 monetary D D Interest Expense, Federal Home Loan Bank and Federal Reserve Bank Advances, Long-Term Interest expense incurred during the reporting period on long-term borrowings associated with Federal Home Loan Bank and Federal Reserve Bank advances.
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities us-gaap/2025 0 0 monetary D D Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Proceeds From Sale Of Restricted Investments us-gaap/2025 0 0 monetary D D Proceeds from Sale of Restricted Investments The cash inflow associated with the sale of investments that are pledged or subject to withdrawal restrictions during the period.
Stock Issued During Period Shares Employee Stock Purchase Plans us-gaap/2025 0 0 shares D Stock Issued During Period, Shares, Employee Stock Purchase Plans Number of shares issued during the period as a result of an employee stock purchase plan.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2025 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Cash Cash Equivalents And Federal Funds Sold us-gaap/2025 0 0 monetary I D Cash, Cash Equivalents, and Federal Funds Sold The sum of cash and cash equivalents plus Federal Funds Sold. Cash and cash equivalents consist of short term, highly liquid investments that are readily convertible to known amounts of cash and are so near their maturity that they present negligible risk of changes in value due to changes in interest rates -- usually with an original maturity less than 90 days.
Interest Receivable us-gaap/2025 0 0 monetary I D Interest Receivable Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.
Equipment Expense us-gaap/2025 0 0 monetary D D Equipment Expense This element represents equipment expense including depreciation, repairs, rentals, and service contract costs. This item also includes equipment purchases which do not qualify for capitalization in accordance with the entity's accounting policy. This item may also include furniture expenses.
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax us-gaap/2025 0 0 monetary D D OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.
Increase Decrease In Deposits us-gaap/2025 0 0 monetary D D Increase (Decrease) in Deposits The net cash inflow or outflow for the increase (decrease) in the beginning and end of period deposits balances.
Noninterest Bearing Deposit Liabilities us-gaap/2025 0 0 monetary I C Noninterest-Bearing Deposit Liabilities The aggregate amount of all domestic and foreign noninterest-bearing deposits liabilities held by the entity.
Noninterest Expense Directors Fees us-gaap/2025 0 0 monetary D D Director Fee Amount of expense for service provided by entity's director.
Occupancy Net us-gaap/2025 0 0 monetary D D Occupancy, Net Amount of net occupancy expense that may include items, such as depreciation of facilities and equipment, lease expenses, property taxes and property and casualty insurance expense.
Other Assets us-gaap/2025 0 0 monetary I D Other Assets Amount of assets classified as other.
Other Noninterest Expense us-gaap/2025 0 0 monetary D D Other Noninterest Expense Amount of noninterest expense classified as other.
Payments To Acquire Life Insurance Policies us-gaap/2025 0 0 monetary D C Payment to Acquire Life Insurance Policy, Investing Activities Amount of cash outflow for payment of premium on corporate-owned life insurance policy, classified as investing activities. Includes, but is not limited to, bank-owned life insurance policy.
Other Comprehensive Income Loss Reclassification Adjustment From A O C I For Sale Of Securities Before Tax us-gaap/2025 0 0 monetary D D Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.
Payments To Acquire Restricted Investments us-gaap/2025 0 0 monetary D C Payments to Acquire Restricted Investments The cash outflow to acquire investments (not to include restricted cash) that are pledged or subject to withdrawal restrictions.
Interest And Fee Income Loan Tax Exempt 0001999371-25-005747 1 0 monetary D C Tax-exempt Amount of operating interest income, including amortization and accretion of premiums and discounts, on securities exempt from state, federal and other income tax.
Proceeds From Repayments Of Short Term Debt us-gaap/2025 0 0 monetary D D Proceeds from (Repayments of) Short-Term Debt The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.
Earnings Per Share Basic us-gaap/2025 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Payments To Acquire Property Plant And Equipment us-gaap/2025 0 0 monetary D C Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Shares Outstanding us-gaap/2025 0 0 shares I Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury.
Common Stock Dividends Per Share Cash Paid us-gaap/2025 0 0 perShare D Common Stock, Dividends, Per Share, Cash Paid Aggregate dividends paid during the period for each share of common stock outstanding.
Fees And Commissions Fiduciary And Trust Activities 0001999371-25-005747 1 0 monetary D C Trust Represents fees and commissions from fiduciary and trust activities.
Interest And Dividend Income Operating us-gaap/2025 0 0 monetary D C Interest and Dividend Income, Operating Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.
Transfer Of Portfolio Loans And Leases To Held For Sale1 us-gaap/2025 0 0 monetary D C Loan and Lease, Transfer from Held-in-Portfolio to Held-for-Sale Value of loans and leases held in the entity's portfolio transferred to loans and leases held-for-sale in noncash transactions.
Interest And Fee Income Loan Taxable 0001999371-25-005747 1 0 monetary D C Taxable Interest and fee income derived from loans issued which are subject to federal income taxes.
Net Cash Provided By Used In Financing Activities us-gaap/2025 0 0 monetary D D Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.
Common Stock Shares Outstanding us-gaap/2025 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Deferred Income Tax Expense Benefit us-gaap/2025 0 0 monetary D D Deferred Income Tax Expense (Benefit) Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Dividends Common Stock Cash us-gaap/2025 0 0 monetary D D Dividends, Common Stock, Cash Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.
Federal Deposit Insurance Corporation Premium Expense us-gaap/2025 0 0 monetary D D Federal Deposit Insurance Corporation Premium Expense Amount of expense for Federal Deposit Insurance Corporation (FDIC) insurance.
Interest Income Expense After Provision For Loan Loss us-gaap/2025 0 0 monetary D C Interest Income (Expense), after Provision for Loan Loss Amount of interest income or expense, including any amortization and accretion (as applicable) of discounts and premiums, including consideration of the provisions for loan, lease, credit, and other related losses.
Other Comprehensive Income Loss Reclassification Adjustment From A O C I For Sale Of Securities Tax us-gaap/2025 0 0 monetary D C Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax us-gaap/2025 0 0 monetary D C OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.
Other Noncash Income Expense us-gaap/2025 0 0 monetary D C Other Noncash Income (Expense) Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.
Payments For Proceeds From Loans And Leases us-gaap/2025 0 0 monetary D C Payments for (Proceeds from) Loans and Leases The net cash outflow or inflow for the increase (decrease) in the beginning and end of period of loan and lease balances which are not originated or purchased specifically for resale. Includes cash payments and proceeds associated with (a) loans held-for-investment, (b) leases held-for-investment, and (c) both.
Short Term Borrowings us-gaap/2025 0 0 monetary I C Short-Term Debt Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.
Assets us-gaap/2025 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Liabilities And Stockholders Equity us-gaap/2025 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Net Income Loss us-gaap/2025 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Stockholders Equity us-gaap/2025 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Common Stock Par Or Stated Value Per Share us-gaap/2025 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Interest Payable Current And Noncurrent us-gaap/2025 0 0 monetary I C Interest Payable Amount of interest payable on debt, including, but not limited to, trade payables.
Debt Securities Available For Sale Gain Loss us-gaap/2025 0 0 monetary D C Debt Securities, Available-for-Sale, Gain (Loss) Amount of unrealized and realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Goodwill us-gaap/2025 0 0 monetary I D Goodwill Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.
Noncash Merger Related Costs us-gaap/2025 0 0 monetary D D Noncash Merger Related Costs Amount of expense (income) related to the increase (decrease) in reserve for business combination costs. Includes, but is not limited to, legal, accounting, and other costs incurred to consummate the merger.
Income Tax Expense Benefit us-gaap/2025 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Other Comprehensive Income Loss Net Of Tax us-gaap/2025 0 0 monetary D C Other Comprehensive Income (Loss), Net of Tax Amount after tax and reclassification adjustments of other comprehensive income (loss).
Service Charges And Fees Income 0001999371-25-005747 1 0 monetary D C Service charges and fees The amount of non-interest income from service charges and fees.
Liabilities us-gaap/2025 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Interest Expense Operating us-gaap/2025 0 0 monetary D D Interest Expense, Operating Amount of interest expense classified as operating.
Amortization Of Financing Costs And Discounts us-gaap/2025 0 0 monetary D D Amortization of Debt Issuance Costs and Discounts Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.
Brokerage Commissions Revenue us-gaap/2025 0 0 monetary D C Brokerage Commissions Revenue Amount of commission revenue from buying and selling securities on behalf of customers.
Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss us-gaap/2025 0 0 monetary I D Financing Receivable, Excluding Accrued Interest, after Allowance for Credit Loss Amortized cost excluding accrued interest, after allowance for credit loss, of financing receivable. Excludes net investment in lease.
Foreclosed Assets us-gaap/2025 0 0 monetary I D Repossessed Assets Carrying amount as of the balance sheet date of all assets obtained in full or partial satisfaction of a debt arrangement through foreclosure proceedings or defeasance; includes real and personal property; equity interests in corporations, partnerships, and joint ventures; and beneficial interests in trusts.
Increase Decrease In Accrued Interest Receivable Net us-gaap/2025 0 0 monetary D C Increase (Decrease) in Accrued Interest Receivable, Net The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.
Interest Income Deposits With Financial Institutions us-gaap/2025 0 0 monetary D C Interest Income, Deposits with Financial Institutions Interest income derived from funds deposited with both domestic and foreign financial institutions including funds in money market and other accounts.
Interest Income Securities Taxable us-gaap/2025 0 0 monetary D C Interest Income, Securities, Operating, Taxable Amount of operating interest income, including amortization and accretion of premiums and discounts, on securities subject to state, federal and other income tax.
Interest Income Securities Tax Exempt us-gaap/2025 0 0 monetary D C Interest Income, Securities, Operating, Tax Exempt Amount of operating interest income, including amortization and accretion of premiums and discounts, on securities exempt from state, federal and other income tax.
Interest Paid Net us-gaap/2025 0 0 monetary D C Interest Paid, Excluding Capitalized Interest, Operating Activity Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Proceeds From Sale Of Available For Sale Securities Debt us-gaap/2025 0 0 monetary D D Proceeds from Sale of Debt Securities, Available-for-Sale Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Noninterest Income us-gaap/2025 0 0 monetary D C Noninterest Income The total amount of noninterest income which may be derived from: (1) fees and commissions; (2) premiums earned; (3) insurance policy charges; (4) the sale or disposal of assets; and (5) other sources not otherwise specified.
Other Amortization Of Deferred Charges us-gaap/2025 0 0 monetary D D Amortization of Other Deferred Charges Amount of amortization of other deferred costs recognized in the income statement.
Provision For Loan Lease And Other Losses us-gaap/2025 0 0 monetary D D Provision for Loan, Lease, and Other Losses Amount of expense related loan transactions, lease transactions, credit loss from transactions other than loan and lease transactions, and other loss based on assessment of uncollectability from the counterparty to reduce the account to their net realizable value.
Proceeds From Other Deposits us-gaap/2025 0 0 monetary D D Proceeds from Other Deposits Amount of cash inflow for receipts of deposits classified as other.
Treasury Stock Common Shares us-gaap/2025 0 0 shares I Treasury Stock, Common, Shares Number of previously issued common shares repurchased by the issuing entity and held in treasury.
Restricted Investments us-gaap/2025 0 0 monetary I D Restricted Investments Investments which are not defined as or included in marketable (debt, equity, or other) securities whose use is restricted in whole or in part, generally by contractual agreements or regulatory requirements. For use in an unclassified balance sheet.
Salaries Wages And Officers Compensation us-gaap/2025 0 0 monetary D D Salary and Wage, Excluding Cost of Good and Service Sold Amount of expense for salary and wage arising from service rendered by nonofficer and officer employees. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2025 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Amortization Of Investment In Limited Partnerships 0001999371-25-005747 1 0 monetary D D Amortization of investment in limited partnerships Amortization of investment in limited partnerships.
Atm And Interchange Expenses 0001999371-25-005747 1 0 monetary D D Automated teller machine and interchange Non interest expenses related to ATM services and interchange.
Additional Paid In Capital Common Stock us-gaap/2025 0 0 monetary I C Additional Paid in Capital, Common Stock Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 0 0 monetary I D Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Communication us-gaap/2025 0 0 monetary D D Communication The amount of expense incurred in the period for communication, which is the exchange of information by several methods.
Stock Issued During Period Value Employee Stock Purchase Plan us-gaap/2025 0 0 monetary D C Stock Issued During Period, Value, Employee Stock Purchase Plan Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.
Treasury Stock Value us-gaap/2025 0 0 monetary I D Treasury Stock, Value The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.
Financing Receivable Allowance For Credit Loss Excluding Accrued Interest us-gaap/2025 0 0 monetary I C Financing Receivable, Allowance for Credit Loss, Excluding Accrued Interest Amount excluding accrued interest, of allowance for credit loss on financing receivable. Excludes net investment in lease.
Interest Expense Deposits us-gaap/2025 0 0 monetary D D Interest Expense, Deposits Aggregate amount of interest expense on all deposits.
Loans Receivable Held For Sale Amount us-gaap/2025 0 0 monetary I D Financing Receivable, Held-for-Sale Amount, before valuation allowance, of financing receivable classified as held-for-sale.
Interest Expense Short Term Borrowings us-gaap/2025 0 0 monetary D D Interest Expense, Short-Term Borrowings The aggregate interest expense incurred on short-term borrowings including commercial paper and Federal funds purchased and securities sold under agreements to repurchase.
Investments In Affiliates Subsidiaries Associates And Joint Ventures us-gaap/2025 0 0 monetary I D Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Amount of investment in equity method investee and investment in and advance to affiliate.
Other Interest And Dividend Income us-gaap/2025 0 0 monetary D C Other Interest and Dividend Income Amount, after discount, accretion and premium amortization, of interest income and dividend income classified as other.
Payments For Origination Of Mortgage Loans Held For Sale us-gaap/2025 0 0 monetary D C Payment for Origination, Loan, Mortgage, Held-for-Sale The amount of cash paid for the origination of mortgages that are held for sale.
Repayments Of Federal Home Loan Bank Borrowings us-gaap/2025 0 0 monetary D C Payments of FHLBank Borrowings, Financing Activities Amount of cash outflow for repayment of Federal Home Loan Bank (FHLBank) borrowing, classified as financing activity.
Non Interest Income Interchange Fees 0001999371-25-005747 1 0 monetary D C Interchange fees Interchange income is a discount on the payment due from the card-issuing bank to the merchant bank through the interchange network.
State Shares Tax Net 0001999371-25-005747 1 0 monetary D D Pennsylvania shares tax Non-interest expense (income) related to state shares tax.
Net Cash Provided By Used In Operating Activities us-gaap/2025 0 0 monetary D Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.
Retained Earnings Accumulated Deficit us-gaap/2025 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Common Stock Value us-gaap/2025 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Accretion Amortization Of Discounts And Premiums Investments us-gaap/2025 0 0 monetary D C Accretion (Amortization) of Discounts and Premiums, Investments The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.
Federal Home Loan Bank Advances Long Term us-gaap/2025 0 0 monetary I C Long-Term Federal Home Loan Bank Advances Including both current and noncurrent portions, Federal Home Loan Bank borrowings initially due beyond one year or beyond the normal operating cycle if longer.
Other Liabilities us-gaap/2025 0 0 monetary I C Other Liabilities Amount of liabilities classified as other.
Payments Of Dividends Common Stock us-gaap/2025 0 0 monetary D C Payments of Ordinary Dividends, Common Stock Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.
Proceeds From Sale Of Mortgage Loans Held For Sale us-gaap/2025 0 0 monetary D D Proceeds from Sale, Loan, Mortgage, Held-for-Sale The cash inflow from sales of loans that are secured with real estate mortgages and are held with the intention to resell in the near future.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001999371-25-005747 2 2 BS 0 H Cash And Due From Banks us-gaap/2025 Cash and due from banks 0
0001999371-25-005747 5 1 CI 0 H Net Income Loss us-gaap/2025 Net Income 0
0001999371-25-005747 2 3 BS 0 H Interest Bearing Deposits In Banks us-gaap/2025 Interest-bearing deposits in other banks 0
0001999371-25-005747 2 4 BS 0 H Cash Cash Equivalents And Federal Funds Sold us-gaap/2025 Total cash and cash equivalents 0
0001999371-25-005747 2 5 BS 0 H Available For Sale Securities Debt Securities us-gaap/2025 Available-for-sale debt securities, at fair value 0
0001999371-25-005747 2 6 BS 0 H Equity Securities Fv Ni Current And Noncurrent us-gaap/2025 Marketable equity securities, at fair value 0
0001999371-25-005747 2 7 BS 0 H Restricted Investments us-gaap/2025 Restricted investment in bank stocks, at cost 0
0001999371-25-005747 2 8 BS 0 H Loans Receivable Held For Sale Amount us-gaap/2025 Loans held for sale 0
0001999371-25-005747 2 9 BS 0 H Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss us-gaap/2025 Loans receivable 0
0001999371-25-005747 2 10 BS 0 H Financing Receivable Allowance For Credit Loss Excluding Accrued Interest us-gaap/2025 Allowance for credit losses 1
0001999371-25-005747 2 11 BS 0 H Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss us-gaap/2025 Loans, net 0
0001999371-25-005747 2 12 BS 0 H Property Plant And Equipment Net us-gaap/2025 Premises and equipment, net 0
0001999371-25-005747 2 13 BS 0 H Foreclosed Assets us-gaap/2025 Foreclosed assets held for sale 0
0001999371-25-005747 2 14 BS 0 H Interest Receivable us-gaap/2025 Accrued interest receivable 0
0001999371-25-005747 2 15 BS 0 H Bank Owned Life Insurance us-gaap/2025 Bank-owned life insurance 0
0001999371-25-005747 2 16 BS 0 H Investments In Affiliates Subsidiaries Associates And Joint Ventures us-gaap/2025 Investment in limited partnerships 0
0001999371-25-005747 2 17 BS 0 H Deferred Income Tax Assets Net us-gaap/2025 Deferred tax asset, net 0
0001999371-25-005747 2 18 BS 0 H Goodwill us-gaap/2025 Goodwill 0
0001999371-25-005747 2 19 BS 0 H Finite Lived Intangible Assets Net us-gaap/2025 Other intangible assets, net 0
0001999371-25-005747 2 20 BS 0 H Other Assets us-gaap/2025 Other assets 0
0001999371-25-005747 2 21 BS 0 H Assets us-gaap/2025 TOTAL ASSETS 0
0001999371-25-005747 2 23 BS 0 H Interest Bearing Deposit Liabilities us-gaap/2025 Interest-bearing deposits 0
0001999371-25-005747 2 24 BS 0 H Noninterest Bearing Deposit Liabilities us-gaap/2025 Noninterest-bearing deposits 0
0001999371-25-005747 2 25 BS 0 H Deposits us-gaap/2025 Total deposits 0
0001999371-25-005747 2 26 BS 0 H Short Term Borrowings us-gaap/2025 Short-term borrowings 0
0001999371-25-005747 2 27 BS 0 H Federal Home Loan Bank Advances Long Term us-gaap/2025 Long-term borrowings 0
0001999371-25-005747 2 28 BS 0 H Interest Payable Current And Noncurrent us-gaap/2025 Accrued interest payable 0
0001999371-25-005747 2 29 BS 0 H Other Liabilities us-gaap/2025 Other liabilities 0
0001999371-25-005747 2 30 BS 0 H Liabilities us-gaap/2025 TOTAL LIABILITIES 0
0001999371-25-005747 2 32 BS 0 H Common Stock Value us-gaap/2025 Common stock, par value $1.25 per share; 15,000,000 shares authorized; issued 3,842,691 and outstanding 3,533,966 at March 31, 2025; issued 3,841,438 and outstanding 3,532,713 at December 31, 2024 0
0001999371-25-005747 2 33 BS 0 H Additional Paid In Capital Common Stock us-gaap/2025 Additional paid-in capital 0
0001999371-25-005747 2 34 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2025 Retained earnings 0
0001999371-25-005747 2 35 BS 0 H Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax us-gaap/2025 Accumulated other comprehensive loss 0
0001999371-25-005747 2 36 BS 0 H Treasury Stock Value us-gaap/2025 Treasury stock, at cost; 308,725 shares at March 31, 2025 and December 31, 2024 1
0001999371-25-005747 2 37 BS 0 H Stockholders Equity us-gaap/2025 TOTAL STOCKHOLDERS EQUITY 0
0001999371-25-005747 2 38 BS 0 H Liabilities And Stockholders Equity us-gaap/2025 TOTAL LIABILITIES AND STOCKHOLDERS EQUITY 0
0001999371-25-005747 3 1 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2025 Common stock, par value (in dollars per share) 0
0001999371-25-005747 3 2 BS 1 H Common Stock Shares Authorized us-gaap/2025 Common stock, shares authorized 0
0001999371-25-005747 3 3 BS 1 H Common Stock Shares Issued us-gaap/2025 Common stock, shares issued 0
0001999371-25-005747 3 4 BS 1 H Common Stock Shares Outstanding us-gaap/2025 Common stock, shares, outstanding 0
0001999371-25-005747 3 5 BS 1 H Treasury Stock Common Shares us-gaap/2025 Treasury stock, shares 0
0001999371-25-005747 4 3 IS 0 H Interest And Fee Income Loan Taxable 0001999371-25-005747 Taxable 0
0001999371-25-005747 4 4 IS 0 H Interest And Fee Income Loan Tax Exempt 0001999371-25-005747 Tax-exempt 0
0001999371-25-005747 4 6 IS 0 H Interest Income Securities Taxable us-gaap/2025 Taxable 0
0001999371-25-005747 4 7 IS 0 H Interest Income Securities Tax Exempt us-gaap/2025 Tax-exempt 0
0001999371-25-005747 4 8 IS 0 H Other Interest And Dividend Income us-gaap/2025 Dividend and other interest income 0
0001999371-25-005747 4 9 IS 0 H Interest Income Deposits With Financial Institutions us-gaap/2025 Deposits in other banks 0
0001999371-25-005747 4 10 IS 0 H Interest And Dividend Income Operating us-gaap/2025 TOTAL INTEREST AND DIVIDEND INCOME 0
0001999371-25-005747 4 12 IS 0 H Interest Expense Deposits us-gaap/2025 Deposits 0
0001999371-25-005747 4 13 IS 0 H Interest Expense Short Term Borrowings us-gaap/2025 Short-term borrowings 0
0001999371-25-005747 4 14 IS 0 H Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term us-gaap/2025 Long-term borrowings 0
0001999371-25-005747 4 15 IS 0 H Interest Expense Operating us-gaap/2025 TOTAL INTEREST EXPENSE 0
0001999371-25-005747 4 16 IS 0 H Interest Income Expense Net us-gaap/2025 NET INTEREST INCOME 0
0001999371-25-005747 4 17 IS 0 H Provision For Loan Lease And Other Losses us-gaap/2025 PROVISION FOR CREDIT LOSSES 0
0001999371-25-005747 4 18 IS 0 H Interest Income Expense After Provision For Loan Loss us-gaap/2025 NET INTEREST INCOME AFTER PROVISION FOR CREDIT LOSSES 0
0001999371-25-005747 4 20 IS 0 H Service Charges And Fees Income 0001999371-25-005747 Service charges and fees 0
0001999371-25-005747 4 21 IS 0 H Non Interest Income Interchange Fees 0001999371-25-005747 Interchange fees 0
0001999371-25-005747 4 22 IS 0 H Gain Loss On Sales Of Loans Net us-gaap/2025 Gain on sale of loans 0
0001999371-25-005747 4 23 IS 0 H Bank Owned Life Insurance Income us-gaap/2025 Earnings on bank-owned life insurance 0
0001999371-25-005747 4 24 IS 0 H Brokerage Commissions Revenue us-gaap/2025 Brokerage 0
0001999371-25-005747 4 25 IS 0 H Fees And Commissions Fiduciary And Trust Activities 0001999371-25-005747 Trust 0
0001999371-25-005747 4 26 IS 0 H Equity Securities Fv Ni Gain Loss us-gaap/2025 Losses on marketable equity securities 0
0001999371-25-005747 4 27 IS 0 H Debt Securities Available For Sale Gain Loss us-gaap/2025 Realized losses on available-for-sale debt securities, net 0
0001999371-25-005747 4 28 IS 0 H Noninterest Income Other Operating Income us-gaap/2025 Other non-interest income 0
0001999371-25-005747 4 29 IS 0 H Noninterest Income us-gaap/2025 TOTAL NON-INTEREST INCOME 0
0001999371-25-005747 4 31 IS 0 H Salaries Wages And Officers Compensation us-gaap/2025 Salaries and employee benefits 0
0001999371-25-005747 4 32 IS 0 H Occupancy Net us-gaap/2025 Occupancy 0
0001999371-25-005747 4 33 IS 0 H Equipment Expense us-gaap/2025 Furniture and equipment 0
0001999371-25-005747 4 34 IS 0 H State Shares Tax Net 0001999371-25-005747 Pennsylvania shares tax 0
0001999371-25-005747 4 35 IS 0 H Professional Fees us-gaap/2025 Professional fees 0
0001999371-25-005747 4 36 IS 0 H Noninterest Expense Directors Fees us-gaap/2025 Directors fees 0
0001999371-25-005747 4 37 IS 0 H Federal Deposit Insurance Corporation Premium Expense us-gaap/2025 Federal deposit insurance 0
0001999371-25-005747 4 38 IS 0 H Communication us-gaap/2025 Data processing and telecommunications 0
0001999371-25-005747 4 39 IS 0 H Atm And Interchange Expenses 0001999371-25-005747 Automated teller machine and interchange 0
0001999371-25-005747 4 40 IS 0 H Noncash Merger Related Costs us-gaap/2025 Merger-related expenses 0
0001999371-25-005747 4 41 IS 0 H Amortization Of Intangible Assets us-gaap/2025 Amortization of intangibles 0
0001999371-25-005747 4 42 IS 0 H Other Noninterest Expense us-gaap/2025 Other non-interest expense 0
0001999371-25-005747 4 43 IS 0 H Noninterest Expense us-gaap/2025 TOTAL NON-INTEREST EXPENSE 0
0001999371-25-005747 4 44 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2025 INCOME BEFORE INCOME TAX PROVISION 0
0001999371-25-005747 4 45 IS 0 H Income Tax Expense Benefit us-gaap/2025 INCOME TAX PROVISION 0
0001999371-25-005747 4 46 IS 0 H Net Income Loss us-gaap/2025 NET INCOME 0
0001999371-25-005747 4 47 IS 0 H Earnings Per Share Basic us-gaap/2025 EARNINGS PER SHARE - BASIC 0
0001999371-25-005747 4 48 IS 0 H Earnings Per Share Diluted us-gaap/2025 EARNINGS PER SHARE - DILUTED 0
0001999371-25-005747 4 49 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2025 WEIGHTED AVERAGE SHARES OUTSTANDING - BASIC 0
0001999371-25-005747 4 50 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2025 WEIGHTED AVERAGE SHARES OUTSTANDING - DILUTED 0
0001999371-25-005747 5 3 CI 0 H Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax us-gaap/2025 Unrealized holding gains (losses) on available-for-sale debt securities 0
0001999371-25-005747 5 4 CI 0 H Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax us-gaap/2025 Tax effect 1
0001999371-25-005747 5 5 CI 0 H Other Comprehensive Income Loss Reclassification Adjustment From A O C I For Sale Of Securities Before Tax us-gaap/2025 Net realized losses included in net income 1
0001999371-25-005747 5 6 CI 0 H Other Comprehensive Income Loss Reclassification Adjustment From A O C I For Sale Of Securities Tax us-gaap/2025 Tax effect 0
0001999371-25-005747 5 7 CI 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2025 Other comprehensive income (loss), net 0
0001999371-25-005747 5 8 CI 0 H Comprehensive Income Net Of Tax us-gaap/2025 Comprehensive income 0
0001999371-25-005747 6 10 EQ 0 H Stockholders Equity us-gaap/2025 Beginning balance, value 0
0001999371-25-005747 6 11 EQ 0 H Shares Outstanding us-gaap/2025 Balance at beginning (in shares) 0
0001999371-25-005747 6 12 EQ 0 H Net Income Loss us-gaap/2025 Net income 0
0001999371-25-005747 6 13 EQ 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2025 Other comprehensive income (loss) 0
0001999371-25-005747 6 14 EQ 0 H Stock Issued During Period Value Employee Stock Purchase Plan us-gaap/2025 Common stock issuance under employee stock purchase plan 0
0001999371-25-005747 6 15 EQ 0 H Stock Issued During Period Shares Employee Stock Purchase Plans us-gaap/2025 Common stock issuance under employee stock purchase plan (in shares) 0
0001999371-25-005747 6 16 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2025 Recognition of employee stock purchase plan expense 0
0001999371-25-005747 6 17 EQ 0 H Dividends Common Stock Cash us-gaap/2025 Cash dividends 1
0001999371-25-005747 6 18 EQ 0 H Stockholders Equity us-gaap/2025 Ending balance, value 0
0001999371-25-005747 6 19 EQ 0 H Shares Outstanding us-gaap/2025 Balance at ending (in shares) 0
0001999371-25-005747 7 1 EQ 1 H Common Stock Dividends Per Share Cash Paid us-gaap/2025 Cash dividends (in dollars per share) 0
0001999371-25-005747 8 2 CF 0 H Net Income Loss us-gaap/2025 Net Income 0
0001999371-25-005747 8 4 CF 0 H Provision For Loan Lease And Other Losses us-gaap/2025 Provision for credit losses 0
0001999371-25-005747 8 5 CF 0 H Depreciation Nonproduction us-gaap/2025 Depreciation and amortization of premises and equipment 0
0001999371-25-005747 8 6 CF 0 H Amortization Of Financing Costs And Discounts us-gaap/2025 Accretion of loan fair value adjustments, net 0
0001999371-25-005747 8 7 CF 0 H Other Amortization Of Deferred Charges us-gaap/2025 Amortization of deposit fair value adjustments, net 0
0001999371-25-005747 8 8 CF 0 H Equity Securities Fv Ni Gain Loss us-gaap/2025 Losses on marketable equity securities 1
0001999371-25-005747 8 9 CF 0 H Debt Securities Available For Sale Realized Gain Loss us-gaap/2025 Realized losses on available-for-sale debt securities, net 1
0001999371-25-005747 8 10 CF 0 H Accretion Amortization Of Discounts And Premiums Investments us-gaap/2025 Accretion of investment securities, net 1
0001999371-25-005747 8 11 CF 0 H Gains Losses On Sales Of Other Real Estate us-gaap/2025 Losses on disposal of premises and equipment, net 1
0001999371-25-005747 8 12 CF 0 H Deferred Income Tax Expense Benefit us-gaap/2025 Deferred income taxes 0
0001999371-25-005747 8 13 CF 0 H Gain Loss On Sales Of Loans Net us-gaap/2025 Gain on sale of loans 1
0001999371-25-005747 8 14 CF 0 H Bank Owned Life Insurance Income us-gaap/2025 Earnings on bank-owned life insurance 1
0001999371-25-005747 8 15 CF 0 H Proceeds From Sale Of Mortgage Loans Held For Sale us-gaap/2025 Proceeds from sale of mortgage loans 0
0001999371-25-005747 8 16 CF 0 H Payments For Origination Of Mortgage Loans Held For Sale us-gaap/2025 Originations of mortgage loans held for resale 1
0001999371-25-005747 8 17 CF 0 H Amortization Of Intangible Assets us-gaap/2025 Amortization of intangibles 0
0001999371-25-005747 8 18 CF 0 H Amortization Of Investment In Limited Partnerships 0001999371-25-005747 Amortization of investment in limited partnerships 0
0001999371-25-005747 8 19 CF 0 H Increase Decrease In Accrued Interest Receivable Net us-gaap/2025 Decrease (increase) in accrued interest receivable and other assets 1
0001999371-25-005747 8 20 CF 0 H Increase Decrease In Interest Payable Net us-gaap/2025 Increase in accrued interest payable and other liabilities 0
0001999371-25-005747 8 21 CF 0 H Other Noncash Income Expense us-gaap/2025 Other, net 1
0001999371-25-005747 8 22 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2025 Net cash provided by operating activities 0
0001999371-25-005747 8 25 CF 0 H Proceeds From Sale Of Available For Sale Securities Debt us-gaap/2025 Proceeds from sales 0
0001999371-25-005747 8 26 CF 0 H Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities us-gaap/2025 Proceeds from paydowns, calls and maturities 0
0001999371-25-005747 8 27 CF 0 H Proceeds From Other Deposits us-gaap/2025 Proceeds from maturities of interest-bearing time deposits 0
0001999371-25-005747 8 28 CF 0 H Payments To Acquire Life Insurance Policies us-gaap/2025 Purchase of bank-owned life insurance 1
0001999371-25-005747 8 29 CF 0 H Proceeds From Sale Of Restricted Investments us-gaap/2025 Proceeds from redemption of restricted investment in bank stocks 0
0001999371-25-005747 8 30 CF 0 H Payments To Acquire Restricted Investments us-gaap/2025 Purchase of restricted investment in bank stocks 1
0001999371-25-005747 8 31 CF 0 H Payments For Proceeds From Loans And Leases us-gaap/2025 Net increase in loans 1
0001999371-25-005747 8 32 CF 0 H Payments To Acquire Intangible Assets us-gaap/2025 Acquisition of customer relationship intangibles 1
0001999371-25-005747 8 33 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2025 Acquisition of premises and equipment 1
0001999371-25-005747 8 34 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2025 Net cash provided by investing activities 0
0001999371-25-005747 8 36 CF 0 H Increase Decrease In Deposits us-gaap/2025 Net increase in deposits 0
0001999371-25-005747 8 37 CF 0 H Proceeds From Repayments Of Short Term Debt us-gaap/2025 Net decrease in short-term borrowings 0
0001999371-25-005747 8 38 CF 0 H Repayments Of Federal Home Loan Bank Borrowings us-gaap/2025 Repayment of long-term borrowings 1
0001999371-25-005747 8 39 CF 0 H Proceeds From Issuance Of Common Stock us-gaap/2025 Proceeds from issuance of common stock 0
0001999371-25-005747 8 40 CF 0 H Payments Of Dividends Common Stock us-gaap/2025 Cash dividends paid 1
0001999371-25-005747 8 41 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2025 Net cash used for financing activities 0
0001999371-25-005747 8 42 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2025 NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 0
0001999371-25-005747 8 43 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 0
0001999371-25-005747 8 44 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 CASH AND CASH EQUIVALENTS, END OF PERIOD 0
0001999371-25-005747 8 46 CF 0 H Interest Paid Net us-gaap/2025 Interest paid 0
0001999371-25-005747 8 47 CF 0 H Transfer Of Portfolio Loans And Leases To Held For Sale1 us-gaap/2025 Loans transferred to foreclosed assets held for sale 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.